Secondary |
Type 2 Diabetes Mellitus |
73.1% |
Product Used For Unknown Indication |
16.4% |
Diabetes Mellitus |
6.0% |
Suicide Attempt |
3.0% |
Hypertension |
1.5% |
|
Hiv Infection |
37.5% |
Pneumocystis Jiroveci Pneumonia |
18.8% |
Rhabdomyolysis |
12.5% |
Hyponatraemia |
6.3% |
Pneumocystis Jirovecii Pneumonia |
6.3% |
Renal Impairment |
6.3% |
Stridor |
6.3% |
Suicide Attempt |
6.3% |
|
Concomitant |
Product Used For Unknown Indication |
26.2% |
Hypertension |
17.5% |
Diabetes Mellitus |
14.4% |
Drug Use For Unknown Indication |
6.1% |
Chronic Myeloid Leukaemia |
4.5% |
Rheumatoid Arthritis |
4.1% |
Type 2 Diabetes Mellitus |
4.0% |
Atrial Fibrillation |
2.9% |
Colitis Ulcerative |
2.7% |
Colorectal Cancer Metastatic |
2.6% |
Hiv Infection |
2.4% |
Prophylaxis |
1.9% |
Aspergillosis |
1.8% |
Arrhythmia |
1.6% |
Hypercholesterolaemia |
1.4% |
Gastritis |
1.3% |
Oedema |
1.3% |
Prophylaxis Against Transplant Rejection |
1.3% |
Cerebrovascular Accident |
1.1% |
Cerebrovascular Accident Prophylaxis |
1.1% |
|
Sepsis |
9.3% |
Death |
7.0% |
Renal Failure Acute |
7.0% |
Varicose Vein |
7.0% |
Weight Decreased |
7.0% |
Melaena |
5.8% |
Pneumonia |
5.8% |
Liver Function Test Abnormal |
4.7% |
Oedema |
4.7% |
Polydipsia |
4.7% |
Somnolence |
4.7% |
Ureteral Stent Insertion |
4.7% |
Liver Disorder |
3.5% |
Lymphopenia |
3.5% |
Renal Impairment |
3.5% |
Swelling |
3.5% |
Transplant Rejection |
3.5% |
Urinary Tract Infection |
3.5% |
Vision Blurred |
3.5% |
Visual Impairment |
3.5% |
|
Interacting |
Hypertension |
62.5% |
Type 2 Diabetes Mellitus |
25.0% |
Cardiovascular Event Prophylaxis |
12.5% |
|
Shock Hypoglycaemic |
100.0% |
|